We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COLL icon
1076
Collegium Pharmaceutical
COLL
$880M
$283K ﹤0.01%
+13,614
New +$246K
LDOS icon
1077
Leidos
LDOS
$17.7B
$283K ﹤0.01%
+3,179
New +$287K
TTGT icon
1078
TechTarget
TTGT
$276M
$283K ﹤0.01%
+6,449
New +$243K
NLY icon
1079
Annaly Capital Management
NLY
$17.4B
$278K ﹤0.01%
9,745
-364,814
-97% -$10.6M
RBC icon
1080
RBC Bearings
RBC
$17.8B
$278K ﹤0.01%
2,289
-2,741
-54% -$351K
NTR icon
1081
Nutrien
NTR
$32B
$275K ﹤0.01%
+7,025
New +$256K
REGI
1082
DELISTED
Renewable Energy Group, Inc.
REGI
$275K ﹤0.01%
+5,144
New +$181K
ITT icon
1083
ITT
ITT
$19.4B
$273K ﹤0.01%
+4,631
New +$281K
XENE icon
1084
Xenon Pharmaceuticals
XENE
$6.2B
$272K ﹤0.01%
24,531
-6,475
-21% -$76.2K
CHU
1085
DELISTED
China Unicom (HONG KONG) Limited
CHU
$272K ﹤0.01%
41,629
+14,771
+55% +$96.9K
BC icon
1086
Brunswick
BC
$5.28B
$271K ﹤0.01%
+4,585
New +$293K
CFR icon
1087
Cullen/Frost Bankers
CFR
$10.3B
$265K ﹤0.01%
+4,156
New +$291K
COOP
1088
DELISTED
Mr. Cooper
COOP
$262K ﹤0.01%
+11,722
New +$202K
TCDA
1089
DELISTED
Tricida, Inc. Common Stock
TCDA
$261K ﹤0.01%
+28,886
New +$422K
CVCO icon
1090
Cavco Industries
CVCO
$4.55B
$260K ﹤0.01%
1,443
-877
-38% -$167K
AXP icon
1091
American Express
AXP
$231B
$259K ﹤0.01%
+2,585
New +$254K
TEX icon
1092
Terex
TEX
$7.79B
$257K ﹤0.01%
+13,257
New +$259K
QIWI
1093
DELISTED
QIWI PLC
QIWI
$255K ﹤0.01%
+14,726
New +$266K
KHC icon
1094
Kraft Heinz
KHC
$29.3B
$254K ﹤0.01%
+8,466
New +$282K
LI icon
1095
Li Auto
LI
$12.3B
$253K ﹤0.01%
+14,526
New +$243K
SRDX
1096
DELISTED
Surmodics
SRDX
$253K ﹤0.01%
6,481
-89
-1% -$3.91K
GPC icon
1097
Genuine Parts
GPC
$18.8B
$251K ﹤0.01%
+2,637
New +$245K
INZY
1098
DELISTED
Inozyme Pharma
INZY
$250K ﹤0.01%
+9,514
New +$236K
AVAV icon
1099
AeroVironment
AVAV
$9.55B
$249K ﹤0.01%
4,142
-50,271
-92% -$3.73M
CCL icon
1100
Carnival Corporation Ltd
CCL
$38.8B
$248K ﹤0.01%
+16,301
New +$252K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.